His face to face meeting was attended in person by the company (Dr Itescu and others) and Dr. Nicole Verdun – being the newly appointed permanent Director of the FDA’s Centre for Biologics Evaluation and Research Office Of Therapeutic Products. The presence of senior leadership from the FDA is an encouraging sign of the intent of the Agency to facilitate an approval for Remestemcel-L
Well Col the way I see it is a deal was made over the Table with the Boss.
In that meeting the Blood and Marrow delegation was present.
SI says he has keep his side of the bargain.
33.5 c
Lets see.
Aloha.
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-287
-
- There are more pages in this discussion • 657 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
1 | 2574 | 1.440 |
1 | 15000 | 1.435 |
2 | 11400 | 1.430 |
1 | 15000 | 1.425 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 14000 | 1 |
1.460 | 14000 | 1 |
1.465 | 14000 | 1 |
1.480 | 50134 | 1 |
1.485 | 40331 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |